DIN 02473623 — SILIQ 210 MG
SILIQ is a solution of Brodalumab marketed by BAUSCH HEALTH, CANADA INC.. The full Brodalumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02473623
- Brand name
- SILIQ
- Active ingredient
- Brodalumab
- Strength
- 210 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- BAUSCH HEALTH, CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Interleukin-17 receptor A (IL-17RA) antagonist (biologic response modifier)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.